Masayo Yamazaki

2.7k citations
33 papers · 2.0k indexed · 1 hit paper · h-index 20
Topics
Drug Transport and Resistance Mechanisms (19 papers)Pharmacological Effects and Toxicity Studies (11 papers)Pharmacogenetics and Drug Metabolism (6 papers)
Partner nations
JapanUnited StatesCanada

In The Last Decade

Masayo Yamazaki

33 papers receiving 2.0k citations

Hit Papers

Role of P-Glycoprotein in Pharmacokinetics20032026201020182003250500750

Peers

Masayo Yamazaki
Comparison fields: 5 of 100
  • Oncology 1.2k
  • Pediatrics, Perinatology and Child Health 723
  • Pharmacology 533
  • Molecular Biology 435
  • Infectious Diseases 257
Replace Katherine S. Fenner with:
Katherine S. Fenner United Kingdom
Liang‐Shang Gan United States
Kenneth R. Brouwer United States
Qingcheng Mao United States
A. David Rodrigues United States
David R. Jones United States
Pankaj B. Desai United States
Yoshiyuki Shirasaka Japan
Miki Katoh Japan
B. Oosterhuis Netherlands
Masayo Yamazaki relative to Katherine S. Fenner United Kingdom Katherine S. Fenner's profile →
Citations per field
00.5×1.6×
Katherine S. Fenner · 1×
Citations per year

Countries citing papers authored by Masayo Yamazaki

Since Specialization
Citations

This map shows the geographic impact of Masayo Yamazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayo Yamazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayo Yamazaki more than expected).

Fields of papers citing papers by Masayo Yamazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masayo Yamazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayo Yamazaki. The network helps show where Masayo Yamazaki may publish in the future.

Co-authorship network of co-authors of Masayo Yamazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Masayo Yamazaki. A scholar is included among the top collaborators of Masayo Yamazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayo Yamazaki. Masayo Yamazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 3
2 24
3 2
4 83
5 37
6 121
7 19
8
Role of P-Glycoprotein in Pharmacokineticsbreakdown →
756
9 36
10 103
11 34
12 71
13 25
14 48
15 16
16 6
17 10
18 7
19
5
20 4

About Masayo Yamazaki

Masayo Yamazaki is a scholar working on Pharmacology, Oncology and Pediatrics, Perinatology and Child Health, having authored 33 papers that have together received 2.0k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (19 papers), Pharmacological Effects and Toxicity Studies (11 papers) and Pharmacogenetics and Drug Metabolism (6 papers). The work is most often cited by research in Pharmacology (533 citations), Oncology (1.2k citations) and Pediatrics, Perinatology and Child Health (723 citations). Masayo Yamazaki has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Jiunn H. Lin, Jerome Hochman, Masato Chiba, Yuichi Sugiyama, Tomoyuki Ohe, I‐Wu Chen, Joy A. Nishime, William Neway, Janice Rowe and J H Lin. Their work appears in journals such as Journal of Biological Chemistry, Hepatology and Journal of Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026